Singapore markets open in 7 hours 39 minutes
Straits Times Index
3,290.70 +24.75 (+0.76%) S&P 500
5,222.68 +8.60 (+0.16%) Dow
39,512.84 +125.04 (+0.32%) Nasdaq
16,340.87 -5.43 (-0.03%) Bitcoin USD
61,520.22 +409.28 (+0.67%) CMC Crypto 200
1,266.74 -91.27 (-6.72%)
Ocular Therapeutix, Inc. (0OT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 04:05PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 813.24M |
| Enterprise value | 434.31M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.30 |
| Price/book (mrq) | 2.13 |
| Enterprise value/revenue | 6.49 |
| Enterprise value/EBITDA | -5.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.46 |
| 52-week change 3 | -10.43% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 10.81 |
| 52-week low 3 | 1.88 |
| 50-day moving average 3 | 7.31 |
| 200-day moving average 3 | 4.54 |
Share statistics
| Avg vol (3-month) 3 | 937 |
| Avg vol (10-day) 3 | 180 |
| Shares outstanding 5 | 154.89M |
| Implied shares outstanding 6 | 156.27M |
| Float 8 | 134.69M |
| % held by insiders 1 | 0.71% |
| % held by institutions 1 | 60.31% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -192.61% |
| Operating margin (ttm) | -214.00% |
Management effectiveness
| Return on assets (ttm) | -17.13% |
| Return on equity (ttm) | -55.19% |
Income statement
| Revenue (ttm) | 59.84M |
| Revenue per share (ttm) | 0.64 |
| Quarterly revenue growth (yoy) | 10.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -88.03M |
| Net income avi to common (ttm) | -115.27M |
| Diluted EPS (ttm) | -1.04 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 482.89M |
| Total cash per share (mrq) | 3.12 |
| Total debt (mrq) | 74.41M |
| Total debt/equity (mrq) | 18.24% |
| Current ratio (mrq) | 21.39 |
| Book value per share (mrq) | 2.64 |
Cash flow statement
| Operating cash flow (ttm) | -84.15M |
| Levered free cash flow (ttm) | -57.92M |
© 2024 Yahoo. All rights reserved.